Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

BACKGROUND: The combination of nivolumab and ipilimumab has been approved for the treatment of multiple solid tumors. This was a phase I study investigating definitive radioimmunotherapy (RIT) with nivolumab and ipilimumab for the treatment of locally advanced (LA) squamous cell carcinoma of the hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Jennifer M, Vathiotis, Ioannis A, Harshyne, Larry A, Ali, Ayesha, Bar Ad, Voichita, Axelrod, Rita, Lorber, Emily, Curry, Joseph, Cognetti, David M, Luginbuhl, Adam J, Tuluc, Madalina, Keith, Scott, Mahoney, Mỹ G, Argiris, Athanassios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401226/
https://www.ncbi.nlm.nih.gov/pubmed/37536941
http://dx.doi.org/10.1136/jitc-2023-007141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401226/
https://www.ncbi.nlm.nih.gov/pubmed/37536941
http://dx.doi.org/10.1136/jitc-2023-007141

Ejemplares similares